0001179110-15-010914.txt : 20150706 0001179110-15-010914.hdr.sgml : 20150703 20150706163450 ACCESSION NUMBER: 0001179110-15-010914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150706 DATE AS OF CHANGE: 20150706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REARDON WILLIAM S CENTRAL INDEX KEY: 0001212646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 15973880 MAIL ADDRESS: STREET 1: 9 STEAMBOAT LANE CITY: HINGHAM STATE: MA ZIP: 02043 4 1 edgar.xml FORM 4 - X0306 4 2015-07-01 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001212646 REARDON WILLIAM S C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2015-07-01 4 A 0 5681 0 A 47120 D Common Stock 2015-07-01 4 A 0 2272 0 A 49392 D Director Stock Option (Right to Buy) 2.2 2015-07-01 4 A 0 20000 0 A 2025-07-01 Common Stock 20000 20000 D Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date. Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as Chairman of the Audit Committee of the Board of Directors of the Issuer on such date. The option vests as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Garrett M. Winslow, Attorney-in-Fact 2015-07-06